查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2017180

內視鏡手術器材市場：依器材類型、應用、操作模式及最終用戶分類－2026-2032年全球市場預測

Endosurgery Device Market by Device Type, Application, Operation Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡手術器械市場價值將達到 348.3 億美元，到 2026 年將成長至 366.3 億美元，到 2032 年將達到 531.2 億美元，複合年成長率為 6.21%。

主要市場統計數據
基準年 2025 348.3億美元
預計年份：2026年 366.3億美元
預測年份 2032 531.2億美元
複合年成長率 (%) 6.21%

本次演講清晰權威地概述了當前影響整個醫療保健系統內視鏡手術器械策略的臨床、技術和營運趨勢。

內視鏡手術器材市場目前正處於轉型期，技術日趨成熟、臨床重點不斷變化以及手術診療流程中操作規範的演變交織在一起。本文概述了微創手術器械的競爭格局和臨床應用，重點在於視覺化、能量傳輸、入路工具和輔助耗材之間的相互作用。此外，本文也著重闡述了光學、電子機械和整合系統領域的進步如何改變手術流程和臨床醫師的選擇偏好。

技術進步、監管預期和供應鏈韌性如何融合，重新定義內視鏡外科醫療設備的價值創造。

在內鏡外科領域，一場變革正在發生，它正在重塑價值創造的結構以及相關人員獲取價值的方式。首先，可視化和成像技術的進步不再局限於漸進式改進，而是為手術提供了多方面的見解。高清光學元件和整合式攝影機系統提高了組織識別的準確性，結合影像校正和人工智慧輔助的疊加功能，它們縮短了掌握複雜微創手術技術所需的時間。這一趨勢正在推動對內視鏡及相關視覺化平台的投資，這些平台能夠與數位化手術室生態系統無縫整合。

評估 2025 年美國關稅調整將如何影響內視鏡手術器械的籌資策略、採購實務和商業化時間表。

美國2025年實施的關稅政策已成為內視鏡手術器械國際供應商和國內買家必須考慮的關鍵營運因素。具體影響包括：需要更加重視供應鏈規劃、合約重新談判以及採購柔軟性。與依賴單一離岸供應鏈的公司相比，擁有垂直整合業務結構和近岸生產能力的製造商更有能力應對不斷上漲的成本壓力。

將醫療設備分類、臨床專科、醫療機構和營運模式與其各自的採用和採購趨勢連結起來的綜合細分分析。

精細的市場細分技術揭示了每種醫療設備類型、臨床應用、最終用戶和操作模式的不同採用模式、報銷考量和採購因素。基於器械類型，市場分析檢驗了內視鏡和視覺化系統、能量器械、供氣設備、腹腔鏡器械、組織粉碎器和組織取回袋。內視鏡和視覺化系統進一步細分為攝影系統、軟式內視鏡和硬式內視鏡，而能量器材則進一步分為電外科器材、雷射器材和超音波器材。這些分類至關重要，因為每個子類別都遵循不同的創新週期和臨床醫生採用過程。

在全球內視鏡手術市場中，醫療保健系統、採購實務和製造趨勢的區域差異如何塑造差異化的打入市場策略。

區域趨勢對全球內視鏡手術市場的產品策略、監管應對方案和商業性重點有顯著影響。在美洲，人們越來越重視能夠證明臨床路徑中運作效率、手術處理能力和治療效果均有所提升的證據。這促使人們對能夠縮短手術時間和降低併發症率的整合式視覺化平台和節能設備產生了濃厚的興趣。此外，這些市場中支付方的嚴格審查和醫院整合也推動了對強力的成本效益論點和可跨多個臨床科室部署的多功能產品系列的需求。

在採購內視鏡手術設備時，對競爭定位、夥伴關係模式和商業策略的評估決定了哪些公司能夠獲得長期合約。

內視鏡手術器材領域的競爭格局由成熟的平台供應商、專注於特定領域的創新企業以及新興的區域性製造商組成。成熟企業持續投資於平台整合、系統互通性和廣泛的臨床研究，以保持其在關鍵器材類別中的領先地位。同時，專注於特定領域的創新企業也在推動技術進步，例如超音波發生器和一次性器材創新。

針對整個內視鏡手術器材產品組合，制定製造商和醫療保健提供者的具體策略重點，以加速產品採用、提高韌性並創造價值。

產業領導者必須採取一系列切實可行的優先事項，將新機會轉化為永續的競爭優勢。首先，投資於臨床證據項目，將醫療設備的使用與治療效果的顯著改善和工作流程的最佳化聯繫起來，從而為醫院和門診採購負責人構建引人注目的價值提案。其次，實現製造地多元化，並對關鍵零件的替代供應商進行認證，以降低貿易政策變更和供應鏈中斷帶來的風險。

採用透明的混合方法研究途徑，結合臨床醫師的見解、監管記錄、臨床文獻和供應鏈分析，得出可靠的結論。

本研究採用混合方法進行綜合分析，結合了對臨床醫生、採購經理和行業高管的訪談，以及對監管文件、臨床文獻和公開資訊的二次分析。訪談提供了有關醫療設備可用性、臨床偏好和採購行為的背景信息，而二次資訊則用於檢驗監管時間表、醫療設備核准情況和技術擴散趨勢。

為了維持內視鏡手術器材的長期相關性，我們需要整合將技術潛力、臨床有效性和營運彈性連結起來的策略挑戰。

總之，內視鏡手術器材市場格局複雜，但也蘊藏著許多機遇，這主要得益於可視化技術的進步、能量模式的多樣化以及人們對一次性使用和互通性需求的不斷變化。能夠將產品創新與可證實的臨床效益、靈活的經營模式和穩健的供應鏈相結合的製造商，將更有利於加速產品在所有醫療機構中的普及應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡手術器械市場：依器械類型分類

  • 內視鏡和視覺化系統
    • 網路攝影系統
    • 軟式內視鏡
    • 硬式內視鏡
  • 能源設備
    • 電外科設備
    • 雷射設備
    • 超音波設備
  • 供氣設備
  • 腹腔鏡器械
  • 碎切器
  • 紙巾收集袋

第9章 內視鏡手術器械市場：依應用領域分類

  • 循環系統
  • 耳鼻喉科
  • 一般外科
  • 婦科
  • 泌尿系統

第10章 內視鏡手術器械市場（依用途分類）

  • 一次性的
  • 可重複使用的

第11章 內視鏡手術器械市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 內視鏡手術器械市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 內視鏡手術器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 內視鏡手術器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國內視鏡手術器械市場

第16章：中國內視鏡手術器材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ConMed Corporation
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-0355054AC519

The Endosurgery Device Market was valued at USD 34.83 billion in 2025 and is projected to grow to USD 36.63 billion in 2026, with a CAGR of 6.21%, reaching USD 53.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 34.83 billion
Estimated Year [2026] USD 36.63 billion
Forecast Year [2032] USD 53.12 billion
CAGR (%) 6.21%

A clear and authoritative framing of current clinical, technological, and operational trends shaping endosurgery device strategies across healthcare systems

The endosurgery device landscape is undergoing a convergent period of technological refinement, shifting clinical priorities, and evolving operational expectations within surgical care pathways. This introduction frames the competitive and clinical context for devices that enable minimally invasive procedures, highlighting the interplay between visualization, energy delivery, access tools, and adjunctive consumables. It emphasizes how advances in optics, electromechanics, and integrated systems are altering procedural workflows and clinician preferences.

Clinicians and hospital administrators are increasingly prioritizing devices and platforms that deliver reproducible outcomes, reduce perioperative variability, and support throughput in constrained surgical schedules. Consequently, device manufacturers are investing in improved camera systems, ergonomics for laparoscopy, and energy modalities that offer controlled tissue effect while minimizing collateral damage. At the same time, payers and procurement leaders are scrutinizing lifecycle costs and reprocessing burdens, which influences the balance between disposable and reusable operation modes.

This introduction sets the scene for a deeper exploration of transformative shifts, tariff impacts, segmentation nuance, regional dynamics, corporate strategy, and pragmatic recommendations. It prepares readers to interpret how clinical needs, regulatory expectations, and supply chain pressures combine to shape strategic choices across product development, market entry, and commercialization pathways.

How converging technological advances, regulatory expectations, and supply chain resilience are collectively redefining value creation in endosurgery devices

The endosurgery field is experiencing transformative shifts that are reshaping where value is created and how stakeholders capture it. First, visualization and imaging advances are moving beyond incremental improvements to deliver multimodal intraoperative insight. High-definition optics and integrated camera systems are enabling more precise tissue identification, and when combined with image enhancement and AI-enabled overlays, they are facilitating shorter learning curves for complex minimally invasive techniques. This trend is catalyzing investment in endoscopes and adjacent visualization platforms that integrate seamlessly with digital operating room ecosystems.

Second, diversification of energy platforms is expanding clinical options for hemostasis and tissue dissection. Electrosurgical devices remain a workhorse in many procedures, while laser and ultrasonic modalities increasingly address niche indications where their distinct tissue interaction profiles offer clinical advantages. As clinicians adopt these modalities, manufacturers must provide clear comparative evidence on safety, efficacy, and ease of use to support substitution or complementary use.

Third, the balance between disposable and reusable operation modes is shifting as hospitals weigh infection control, environmental impact, and total cost of ownership. Disposable instruments reduce reprocessing risk and turnover time, whereas reusable systems can lower per-procedure device spend if reprocessing infrastructure is optimized. This dynamic is driving hybrid solutions and modular designs that allow selective disposability of high-risk components.

Fourth, regulatory rigor and supply chain resilience have moved to the forefront in response to prior disruptions. Manufacturers are redesigning sourcing strategies, increasing component redundancy, and engaging earlier with regulators to expedite approvals while maintaining compliance. These structural changes are altering time-to-market calculations and emphasizing quality management systems as a competitive differentiator.

Collectively, these shifts are not isolated; they interact to influence product roadmaps, clinical adoption strategies, and procurement decisions. The net result is a market environment where agility, evidence generation, and cross-functional collaboration determine which technologies transition from niche tools to standard-of-care platforms.

Assessment of how 2025 United States tariff adjustments are influencing sourcing strategies, procurement behavior, and commercialization timelines across endosurgery devices

Tariff policy introduced in 2025 in the United States has surfaced as a meaningful operational consideration for international suppliers and domestic purchasers of endosurgery devices. The tangible effect has been a heightened focus on supply chain mapping, contract renegotiation, and sourcing flexibility. Manufacturers with vertically integrated operations or nearshore production capabilities have been positioned to mitigate incremental cost pressures more effectively than firms reliant on a single offshore supply base.

Operations teams have responded by accelerating localization of critical components and qualifying alternative suppliers to reduce exposure to tariff-induced cost volatility. Procurement organizations have revisited legacy agreements to shift more of the total landed cost calculus into forward-looking pricing models that account for duties, freight variability, and inventory carrying costs. These actions have prompted a wave of commercial discussions around adjusted pricing frameworks and longer-term supply commitments.

Clinically, the tariff environment has sometimes delayed scheduled technology rollouts or forced phased introductions where hospitals prioritized capital investments with clearer near-term return on investment. Meanwhile, regulatory and contracting teams have had to reconcile product labeling, customs classification, and documentation to avoid inadvertent duty escalation. From an innovation perspective, tariff-related pressures have encouraged partnerships and licensing arrangements that preserve access to advanced features without necessitating full-scale manufacturing relocations.

In summary, the tariff landscape in 2025 has reinforced the importance of flexible manufacturing footprints, transparent cost-to-serve models, and collaborative commercial strategies. Stakeholders that proactively assess duty exposure, diversify supply chains, and align commercial terms with supply realities are better positioned to sustain adoption momentum despite the headwinds introduced by new trade measures.

Comprehensive segmentation interpretation linking device classes, clinical specialties, care settings, and operation modes to distinct adoption and procurement dynamics

A nuanced segmentation approach illuminates divergent adoption patterns, reimbursement considerations, and procurement drivers across device types, clinical applications, end users, and operation modes. Based on Device Type, market analysis examines Endoscopes And Visualization Systems, Energy Devices, Insufflators, Laparoscopic Instruments, Morcellators, and Tissue Retrieval Bags, with Endoscopes And Visualization Systems further parsed into Camera Systems, Flexible Endoscopes, and Rigid Endoscopes, and Energy Devices further explored across Electrosurgical Devices, Laser Devices, and Ultrasonic Devices; these distinctions matter because each subgroup follows different innovation cycles and clinician acceptance pathways.

Based on Application, the study spans Cardiovascular, ENT, General Surgery, Gynecology, and Urology, reflecting how procedural volumes, anatomical complexity, and clinical outcome priorities diverge across specialties and thereby influence device selection. Based on End User, attention is given to Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, as procurement policies, capital expenditure thresholds, and throughput objectives vary considerably between these settings, shaping which devices become preferred. Based on Operation Mode, the disposable versus reusable dichotomy is examined as a strategic axis that affects manufacturing decisions, sterilization workflows, and environmental considerations.

Interpreting these segmentation dimensions together reveals patterns that single-axis analyses miss. For example, rigid endoscopes continue to be predominant in certain ENT procedures where durability and optics are paramount, while flexible endoscopes and advanced camera systems are gaining traction in general surgery and urology due to their maneuverability and visualization advantages. Electrosurgical devices remain widely adopted across specialties because of their versatility, yet ultrasonic and laser systems are carving out niches in procedures where tissue selectivity and reduced thermal spread are decisive. Ambulatory surgical centers show faster uptake of compact, plug-and-play systems that minimize turnover time, whereas large hospitals prioritize integrated platforms that dovetail with enterprise-wide digital health strategies. Finally, the disposable versus reusable calculus is influenced by both clinical risk tolerance and institutional capacity for reprocessing, which can differ markedly between specialty clinics and tertiary hospitals.

These segmentation insights provide a roadmap for aligning product development, clinical evidence generation, and commercial engagement with the distinct requirements of each device subclass, application area, and care setting.

How distinct regional healthcare structures, procurement behaviors, and manufacturing trends are shaping differentiated go-to-market strategies across global endosurgery landscapes

Regional dynamics exert a powerful influence on product strategy, regulatory planning, and commercial prioritization across global endosurgery markets. In the Americas, clinical pathways emphasize operational efficiency, procedural throughput, and evidence demonstrating improved outcomes; this has prompted strong interest in integrated visualization platforms and energy devices that reduce operative time and complication rates. Payer scrutiny and hospital consolidation in these markets also demand robust cost-effectiveness narratives and versatile product portfolios that can be deployed across multiple service lines.

In Europe, Middle East & Africa, health systems present a heterogeneous mix of centralized procurement, national regulatory frameworks, and variable infrastructure maturity. Western European markets often prioritize interoperability with existing hospital systems and adherence to stringent regulatory standards, while emerging markets within the region demonstrate demand for cost-effective, robust devices that can perform reliably in resource-constrained settings. Middle Eastern and African buyers may value supplier responsiveness and aftermarket service capabilities in addition to baseline clinical performance.

Asia-Pacific markets exhibit rapid clinical adoption in certain urban centers, strong investment in surgical capacity expansion, and a growing domestic manufacturing base. These dynamics create both opportunity and competition for international suppliers, as regional OEMs increasingly offer localized alternatives. Moreover, regulatory pathways in several Asia-Pacific countries are evolving to accelerate access to innovative surgical technologies, which necessitates tailored regulatory strategies and local clinical validation to support adoption.

Taken together, these regional characteristics require manufacturers to calibrate go-to-market strategies by balancing global platform consistency with local adaptation. Effective regional approaches combine clinical evidence generation, targeted reimbursement engagement, and service models that reflect the operational realities of each geography.

Evaluating competitive positioning, partnership models, and commercial tactics that determine which companies secure long-term preference in endosurgery device procurement

Competitive dynamics in the endosurgery device arena are shaped by a mix of incumbent platform providers, specialized niche innovators, and emerging regional manufacturers. Established companies continue to invest in platform consolidation, system interoperability, and broad clinical studies to maintain leadership across core device categories. At the same time, focused innovators are driving advancement in discrete areas such as advanced imaging modules, ultrasonic generators, and single-use instrument innovations.

Strategic behaviors to watch include partnership models that combine established distribution networks with technology-enabled startups to accelerate commercialization. Licensing arrangements and co-development agreements are increasingly used to access algorithmic capabilities, sensor technologies, or disposable component designs without incurring full internal R&D costs. Additionally, aftermarket service offerings and performance-based contracting are becoming more visible as companies seek to lock in long-term relationships with large hospital systems.

From an execution perspective, thin margins on commoditized consumables place a premium on operational excellence, whereas differentiated platform features allow for value-based pricing aligned with clinical outcomes. Companies that can demonstrate reproducible clinical benefits, streamlined workflows, and total cost advantages are better positioned to secure preference in procurement dialogs. Finally, corporate strategies that emphasize regulatory preparedness, supply chain redundancy, and a clear sustainability narrative will likely gain favor among institutional buyers prioritizing resilience and environmental stewardship.

Actionable strategic priorities for manufacturers and healthcare providers to accelerate adoption, improve resilience, and capture value across endosurgery device portfolios

Industry leaders must pursue a set of actionable priorities to convert emerging opportunities into sustained advantage. First, invest in clinical evidence programs that link device use to meaningful outcome improvements and workflow efficiencies, thereby creating a defensible value proposition for hospital and ambulatory buyers. Second, diversify manufacturing footprints and qualify alternate suppliers for critical components to reduce exposure to trade policy changes and supply chain interruptions.

Third, develop flexible commercial models that accommodate different purchasing mindsets across care settings; this includes offering modular platforms that support both reusable core systems and disposable adjuncts, as well as subscription or service-based contracts that align vendor incentives with clinical performance. Fourth, build interoperability and digital integration into new products to meet the growing demand for connected operating room ecosystems and to facilitate real-world data capture for post-market surveillance and optimization.

Fifth, accelerate regulatory and reimbursement engagement by preparing robust dossiers early and engaging payers with health economic evidence. Sixth, prioritize aftermarket service excellence and training programs to reduce device downtime and to shorten time-to-proficiency for clinicians adopting new technologies. By pursuing these coordinated actions, leaders can enhance adoption velocity, protect margin, and create sustainable differentiation in a competitive landscape.

Transparent mixed-methods research approach combining clinician insights, regulatory records, clinical literature, and supply chain analysis to ensure robust conclusions

This research synthesis draws on a mixed-methods approach that combines primary interviews with clinicians, procurement leaders, and industry executives with secondary analysis of regulatory filings, clinical literature, and public disclosures. Primary qualitative interviews provided context on device usability, clinical preferences, and procurement behaviors, while secondary sources were used to validate regulatory timelines, device approvals, and technology diffusion trends.

The methodological approach emphasized triangulation to reduce bias: insights from clinician interviews were compared with procurement perspectives and corroborated with product labeling and safety communications. In addition, supply chain analyses reviewed public company disclosures and trade data to map sourcing footprints and identify resilience strategies. Wherever possible, methodology prioritized recent, peer-reviewed clinical studies and device-specific safety information to ground statements about clinical impact and procedural use.

Limitations of the approach include variability in reporting standards across jurisdictions and the uneven availability of head-to-head comparative data for some emerging energy modalities. To mitigate these constraints, the research applied conservative interpretation where direct comparisons were absent and highlighted areas where further controlled clinical evaluation would be beneficial. The result is a rigorous, multi-dimensional view intended to support strategic decision-making without overreliance on any single data source.

Synthesis of strategic imperatives that bridge technological promise, clinical validation, and operational resilience to sustain long-term relevance in endosurgery devices

In conclusion, the endosurgery device landscape presents a complex but navigable set of opportunities driven by improvements in visualization, diversification of energy modalities, and evolving expectations around disposability and interoperability. Manufacturers that align product innovation with demonstrable clinical benefit, flexible commercial models, and resilient supply chains will be better positioned to influence adoption across care settings.

Regional nuance matters: success in the Americas, Europe, Middle East & Africa, and Asia-Pacific requires tailored strategies that reflect local procurement structures, regulatory pathways, and manufacturing realities. Competitive advantage will accrue to organizations that can combine clinical evidence with operational support and sustainable service models. As tariffs and trade dynamics continue to inject uncertainty, agility in sourcing and pricing strategy will remain essential.

Ultimately, the path forward demands coordinated efforts across R&D, regulatory, commercial, and operations teams to translate technological promise into clinical and economic value. Stakeholders who prioritize transparent evidence generation, customer-centric service delivery, and adaptive manufacturing will find the clearest route to long-term relevance and impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endosurgery Device Market, by Device Type

  • 8.1. Endoscopes And Visualization Systems
    • 8.1.1. Camera Systems
    • 8.1.2. Flexible Endoscopes
    • 8.1.3. Rigid Endoscopes
  • 8.2. Energy Devices
    • 8.2.1. Electrosurgical Devices
    • 8.2.2. Laser Devices
    • 8.2.3. Ultrasonic Devices
  • 8.3. Insufflators
  • 8.4. Laparoscopic Instruments
  • 8.5. Morcellators
  • 8.6. Tissue Retrieval Bags

9. Endosurgery Device Market, by Application

  • 9.1. Cardiovascular
  • 9.2. ENT
  • 9.3. General Surgery
  • 9.4. Gynecology
  • 9.5. Urology

10. Endosurgery Device Market, by Operation Mode

  • 10.1. Disposable
  • 10.2. Reusable

11. Endosurgery Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endosurgery Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endosurgery Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endosurgery Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endosurgery Device Market

16. China Endosurgery Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Boston Scientific Corporation
  • 17.7. ConMed Corporation
  • 17.8. Hologic, Inc.
  • 17.9. Intuitive Surgical, Inc.
  • 17.10. Johnson & Johnson
  • 17.11. KARL STORZ SE & Co. KG
  • 17.12. Medtronic plc
  • 17.13. Olympus Corporation
  • 17.14. Smith & Nephew plc
  • 17.15. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSURGERY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSURGERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)